Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, according to new research from the ...
Identifying populations at an increased risk for HIV and preventing outbreaks remain a challenge, but researchers are using tracking technology to find these at-risk individuals and provide treatment, ...
FOSTER CITY, Calif. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next ...
HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration ...
We can’t treat and defeat what we don’t know. Which is why testing is a key component to society’s global ability to fight viruses like HIV, an ever-changing epidemic. For the last 40 years, HIV has ...
Plus: Donald Trump has signed an executive order to delay TikTok's ban This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
News-Medical.Net on MSN
Expanded HIV treatment dramatically reduced orphanhood rates in Uganda
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai, Uganda, ...
A University of Virginia-led team of researchers has made a discovery that may change sepsis treatment for patients in Africa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback